|
Sweet
no more
The diabetic population in India is growing and everyone wants
a piece of the sweet pie. With insurance providers, diagnostic
companies, hospitals and pharma companies focussing on this
segment, Nandini Patwardhan tries to ascertain the potential
of the diabetes market.
Villoo
Morawala-Patell receives Entrepreneur of the Year Award
Dr Villoo Morawala Patell, Founder and Managing Director of
Avesthagen was presented the 'Entrepreneur of the Year 2006'
award at a recently concluded BioSpectrum awards function
in Bangalore.
Lupin’s
Amigra advances to Phase III
Lupin announced that it has received approval from the DCGI
to conduct Phase III clinical trials for its anti-migraine
compound Amigra (LLL-2011). This botanical drug product is
formulated as a nasal spray for use in the prophylaxis of
migraine.
Glenmark's
receives 25 million Euros from Merck
Glenmark Pharmaceuti-cals SA received 25 million Euros from
Merck KgaA in Q3 FY2007, after the anti-trust clearance in
US. This constitutes the upfront payment under the recently
concluded collaboration agreement for Glenmark's DPP-IV inhibitor
GRC 8200, between the two parties.
Granules
and PharmaMatch take on EU markets
PharmaMatch, a Dutch pharmaceutical company and Granules India
signed a memorandum of under-standing to jointly develop,
manufacture and market formulations in the European market.
Akorn-Strides
JV to expand
Strides Arcolab and Akorn have agreed to fund, develop and
commercialise additional 10 ANDA injectable drugs for their
joint venture.
Elder
to market Roche’s drug
Roche has finalised an agreement for its novel postmenopausal
osteoporosis drug, Bonviva which is to be marketed by Elder
Pharmaceuticals in India.
‘The
use of microbiology consumables has gone up’
Dr Rahul Warke, Director R&D of HiMedia, talks to Nancy
Singh about advances in the cell culture medium market vis-à-vis
the pharma industry.
|
